Patient-Centered Decision-Making in Secondary AML Treatment

Panelists discuss how involving patients and caregivers in the treatment decision-making process for secondary acute myeloid leukemia (AML) requires clear communication, education about options, and consideration of individual values and preferences to ensure informed and shared decision-making.

EP: 1.Implementing Updates to AML Classification Guidelines

EP: 2.Treatment Goals in Secondary AML

Now Viewing

EP: 3.Patient-Centered Decision-Making in Secondary AML Treatment

Video content above is prompted by the following:

• How do you involve the patient and their caregivers in the decision-making process when determining the appropriate treatment?

Related Videos